The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy
about
Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategyBreast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonistRecombinant R-spondin2 and Wnt3a up- and down-regulate novel target genes in C57MG mouse mammary epithelial cellsComputational prediction and analysis of breast cancer targets for 6-methyl-1, 3, 8-trichlorodibenzofuranDevelopment of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties.A novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification - implications for chemoprevention.Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA-induced mammary tumors.CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptorThe aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells.In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo.The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasisAh receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines.Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavoneEstimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort.Aryl hydrocarbon receptor ligands in cancer: friend and foe.Activation of the aryl hydrocarbon receptor by TCDD inhibits mammary tumor metastasis in a syngeneic mouse model of breast cancerAryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.Inherent and benzo[a]pyrene-induced differential aryl hydrocarbon receptor signaling greatly affects life span, atherosclerosis, cardiac gene expression, and body and heart growth in miceAryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer CellsAryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.Aryl hydrocarbon receptor ligands inhibit igf-ii and adipokine stimulated breast cancer cell proliferationBeta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling.MicroRNAs in cancer therapeutic response: Friend and foeA Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase.Aryl hydrocarbon receptor induced intratumoral aromatase in breast cancer.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target.Zinc finger nuclease-mediated knockout of AHR or ARNT in human breast cancer cells abolishes basal and ligand-dependent regulation of CYP1B1 and differentially affects estrogen receptor α transactivation.High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation.
P2860
Q26863340-E4C64D45-03E6-4A95-A4E8-C4D4755C2E57Q28475994-36DCB8B4-0C42-41B6-A17D-AEA33DF22960Q28478701-092C01C0-7AA2-41C6-B52F-27EBF50EB1F6Q28544666-8DEF3FB1-258F-4839-9438-ACB4AAD654CAQ33857229-0D703F68-087E-462A-A9BB-D0634C168059Q33968462-033774D9-F486-40BF-8699-B64B24B04344Q34118866-5A5B8FBD-2C5C-4AC1-87D4-E9EE27C5764BQ34131886-B4B99156-6941-40C8-982D-E17E3B28A2F8Q34345424-812BAE25-0921-4E75-AF85-31981DF23716Q34360082-50AFC861-A3B5-48ED-BCAA-EF325354CB62Q34485137-A64D1086-638B-4E70-A61A-A278A2260351Q34605176-E91D4FE9-3A60-4476-8017-27215B977C20Q34701028-82674A1E-FE93-466D-8A7B-26D082F2E62DQ35185520-05AF3F3F-E578-469E-8783-6942D4B7CA38Q35458027-FE2893FE-1D18-46DC-90FA-CB1021E39FE5Q35551010-F371B2E0-E9B9-43A5-9DCF-80EF9711D0E1Q35667189-D5093B17-4F80-45B5-A202-ABADC8B00AAFQ35839549-A5325FDE-BD9D-4B50-9B10-A93691E17637Q36325693-E382DDA6-3490-43BB-A33F-AE5DC01BB23EQ36335539-AF648635-9E81-4F1A-81A1-0B4ACCBECE4CQ37108803-BBAA3EC4-9866-4E2C-9853-4A31A85A0148Q37221957-B27BE34A-26CB-4F6B-B20D-3A14705C9863Q37616066-EC99CD49-E6BF-4006-90AC-911DA8C87391Q38258754-F1FE9439-5104-4BE9-B635-68EB0505DDE1Q38707211-BB484DB1-1C90-40EC-9815-52C13405A7BBQ38728324-D331847B-B22D-4EEA-ADBE-7B4137DEFBFCQ39309007-D87C490D-36D9-4157-841E-301C7EDBF6C2Q42450380-EA5A8302-37F4-4A25-8126-C6987C0E2BCCQ47213795-C746E508-64CE-47F2-8594-2C6CD0D16544Q54859210-417F255F-EF69-492F-8E55-C7615D579AB1
P2860
The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The aryl hydrocarbon receptor ...... ive breast cancer chemotherapy
@en
The aryl hydrocarbon receptor ...... ve breast cancer chemotherapy.
@nl
type
label
The aryl hydrocarbon receptor ...... ive breast cancer chemotherapy
@en
The aryl hydrocarbon receptor ...... ve breast cancer chemotherapy.
@nl
prefLabel
The aryl hydrocarbon receptor ...... ive breast cancer chemotherapy
@en
The aryl hydrocarbon receptor ...... ve breast cancer chemotherapy.
@nl
P2093
P2860
P356
P1476
The aryl hydrocarbon receptor ...... ive breast cancer chemotherapy
@en
P2093
Craig Rowlands
Kelcey Walker
Leela Kotha
Stephen Safe
Xiangrong Li
P2860
P304
P356
10.1677/ERC-09-0054
P577
2009-05-15T00:00:00Z